FindTrial
Sign In

Study on hemoglobin levels for anemia during pregnancy and postpartum.

Redefining Maternal Anemia in Pregnancy and Postpartum (ReMAPP): A multicenter, international, population-based study to establish global hemoglobin thresholds for maternal anemia - sub-study of the ARC study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/03/050450
Enrollment
2000
Registered
2023-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Centre for Health Research and Development Society for Applied Studies
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A pregnant woman who meets the following inclusion criteria may be enrolled in the study: 1. Lives within the study catchment area; 2. Meets minimum age requirement (greater than equal to 18 years) 3. Intrauterine pregnancy less than 14 weeks gestation verified via ultrasound; 4. Provides informed consent

Exclusion criteria

Exclusion criteria: Among women screened for the study, the following are exclusion criteria: 1. Nonviable (e.g. ectopic or molar) pregnancy; 2. Plans to relocate outside of the study catchment area during pregnancy and/or postpartum

Design outcomes

Primary

MeasureTime frame
Maternal health outcomes: 1. Composite severe maternal health outcomes 2. Perinatal depression 3. Postpartum anemia through 42 days postpartum Fetal and neonatal health outcomes: 1. Preterm birth 2. Small-for-gestational age 3. Stillbirth 4. Neonatal mortalityTimepoint: During pregnancy, at delivery point and up to 42 days post-delivery At the time of delivery or up to 28 days of birth—

Secondary

MeasureTime frame
Maternal health outcomes: 1. Maternal mortality, defined as a womanââ?¬â?¢s death during pregnancy and childbirth or within 42 days of termination of pregnancy 2. Late maternal mortality (up to one year post-delivery) 3. Preeclampsia/ eclampsia 4. Postpartum hemorrhage 5. Preterm premature rupture of membranes 6. Maternal sepsis 7. Maternal fatigue Timepoint: During pregnancy, at delivery point and up to one-year post-delivery;Fetal and neonatal health outcomes: 1. Low birthweight 2. Hyperbilirubinemia 3. Neonatal sepsis 4. Possible severe bacterial infection 5. Infant neurodevelopment Timepoint: At the time of delivery or up to 6 weeks of birth—

Countries

India

Contacts

Public ContactDr Sarmila Mazumder

Centre for Health Research and Development, Society for Applied Studies

sarmila.mazumder@sas.org.in011-46043751-55

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026